Jonathan Babia, RN | |
43 Giles Ave, Jersey City, NJ 07306-6405 | |
(201) 435-1652 | |
Not Available |
Full Name | Jonathan Babia |
---|---|
Gender | Male |
Speciality | Registered Nurse |
Location | 43 Giles Ave, Jersey City, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205310414 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 735922 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jonathan Babia, RN 43 Giles Ave, Jersey City, NJ 07306-6405 Ph: (201) 435-1652 | Jonathan Babia, RN 43 Giles Ave, Jersey City, NJ 07306-6405 Ph: (201) 435-1652 |
News Archive
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
As the U.S. Food and Drug Administration (FDA) weighs the evidence on the deadly impact of menthol cigarettes, three African American organizations have spoken out against a potential ban, urging the Tobacco Products Scientific Advisory Committee to consider the negative implications of a ban and to discount any unsubstantiated evidence on menthol.
Osaka University researchers use smartphones and machine learning to measure sleep patterns. Despite spending at least one quarter to one third a day sleeping, good sleep can elude many people, and the diagnosis and treatment of sleep disorders remains primitive.
Designing effective new drugs, especially drugs to fight cancer, demands that you know as much as you can about the molecular workings of cancer growth. Without that, it's like planning to fight a war against an enemy you've never seen.
We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between prostate cancer and benign prostatic hyperplasia (BPH) by "sniffing" urine headspace (the space directly above the urine sample). Results using the eNose are comparable to testing prostate specific antigen (PSA), reports the Journal of Urology.
› Verified 1 days ago
Ms. Marigold Brillantes-benguan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 74 Mcadoo Ave, Jersey City, NJ 07305 Phone: 646-331-5611 | |
Pulcherie Kamga Kenye Fossie, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3688 Kennedy Blvd, Apt-3, Jersey City, NJ 07307 Phone: 718-671-2100 | |
Kristen Mccabe, Registered Nurse Medicare: Medicare Enrolled Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2200 | |
Mr. Daniel Harmeyer, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Anastacia Nyamongo, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 416 Cator Ave # 2, Jersey City, NJ 07305 Phone: 201-705-2324 | |
Jamie Beth Owens, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 116 Mercer St, 1a, Jersey City, NJ 07302 Phone: 203-417-5961 | |
Mrs. Molly Virginia Walker, RN, CNM, MSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Horizon Health Center, 714 Bergen Avenue, Jersey City, NJ 07306 Phone: 201-451-6300 Fax: 201-451-0619 |